What Researchers Did
Researchers conducted a randomized controlled trial involving 565 patients with acute severe intracerebral hemorrhage to investigate the effect and optimal protocol for hyperbaric-oxygen therapy.
What They Found
Compared to the sham-control group, all four hyperbaric-oxygen therapy intervention groups showed significantly improved modified Barthel Index and modified Rankin Scale scores, and significantly decreased mortality rates (all p < 0.005). While upper gastrointestinal bleeding rates were higher in Groups B (60.00%) and C (64.49%) compared to Group A (39.25%), these were not clinically significant. The optimal protocol was identified as 1.5 atmospheres absolute pressure with 60 HBOT exposures.
What This Means for Canadian Patients
Canadian patients with acute severe intracerebral hemorrhage might benefit from hyperbaric-oxygen therapy as an adjunct to emergency craniotomy, potentially improving survival and functional outcomes. This therapy could offer a new treatment option to enhance recovery for those suffering from this severe condition.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada nor involved Canadian researchers or participants.
Study Limitations
The study's primary limitation includes its focus on outcomes only up to six months, which may not capture long-term functional recovery or survival benefits.